Sanuwave Will Host a Conference Call on May 13, 2026 at 8:30 AM (ET) to Present Q1 2026 Financial Results
Rhea-AI Summary
Sanuwave (NASDAQ: SNWV) will host a live conference call on May 13, 2026 at 8:30 AM ET to present Q1 2026 financial results. Telephone and webcast access are provided; replay available through May 27, 2026. Materials will be posted at the company investor website.
Dial-in numbers, conference ID, webcast link, and replay details are available for investors to listen live or on replay.
Positive
- None.
Negative
- None.
News Market Reaction – SNWV
In the May 7 session, SNWV gained 4.59%, reflecting a moderate positive market reaction. Our momentum scanner triggered 2 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Conferences,earnings Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Mar 20 | Earnings call schedule | Neutral | -1.6% | Scheduled call to present Q4 and full-year 2025 financial results. |
| Nov 03 | Earnings call schedule | Neutral | +0.3% | Announced Q3 2025 financial results conference call with replay details. |
| Aug 04 | Earnings call schedule | Neutral | -1.4% | Set Q2 2025 financial results conference call and investor materials access. |
| May 05 | Earnings call schedule | Neutral | -1.2% | Announced Q1 2025 results call with dial-in and replay instructions. |
| Mar 17 | Earnings call schedule | Neutral | +10.4% | Planned call to review Q4 and full-year 2024 financial performance. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Past earnings-call scheduling headlines for SNWV have generally produced modest, mixed single-day moves, with most reactions slightly negative and one notable positive outlier.
Over the past year, SANUWAVE has regularly announced conference calls to discuss quarterly and annual results, including Q1, Q2, Q3 2025 and full-year 2024 and 2025. These “conferences,earnings” notices typically detailed dial-in logistics and replay availability. Price reactions around such scheduling announcements have been small, often within a few percent, contrasting with larger moves seen on preliminary revenue and record earnings updates reported in separate releases.
AI-generated analysis. How Rhea-AI works. Not financial advice.
EDEN PRAIRIE, Minn., May 06, 2026 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Wednesday, May 13, 2026, at 8:30 AM (ET) to present its Q1 2026 financial results.
Telephone access to the call will be available by dialing the following numbers:
Participant Dial-in Information
Toll Free: 1-833-316-1983
Toll/International: 1-785-838-9310
Conference ID: SANUWAVE
OR click the link below to access the live webcast:
https://viavid.webcasts.com/starthere.jsp?ei=1762392&tp_key=537d7338d6
Materials for the conference call will be included on the Company’s website at www.sanuwave.com/investors.
A replay will be made available through Wednesday, May 27, 2026:
Toll-Free: 1-844-512-2921 or 1-412-317-6671
Replay Access ID: 11161765
About Sanuwave
Sanuwave Health is focused on the research, development, and commercialization of its patented, non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures.
Sanuwave's end-to-end wound care portfolio of regenerative medicine products and product candidates help restore the body’s normal healing processes. Sanuwave applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, aesthetic/cosmetic, and cardiac/endovascular conditions.
Forward-Looking Statements
This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to future financial results, production expectations, plans for future business development activities and expectations regarding the impact of changes in tariff rates. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the key risks, assumptions and factors that may affect operating results, performance and financial condition are risks associated with regulatory oversight, the Company’s ability to manage its capital resources, competition and the other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statement.
Contact:
